BioXcel Therapeutics’ $100 Million Public Offering

Martina Bellini
Tagged:

Troutman Pepper Hamilton Sanders LLP advised BioXcel LLC on the deal.BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, announced the pricing of an underwritten…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now